Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8%

Emerald Health Therapeutics, Inc. (CVE:EMHGet Free Report)’s stock price dropped 3.8% during trading on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Stock Down 3.8 %

The company’s 50 day moving average price is C$0.26 and its 200 day moving average price is C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The firm has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37.

Emerald Health Therapeutics Company Profile

(Get Free Report)

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.

Further Reading

Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.